Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors.
M. A. Dickson
No relevant relationships to disclose
P. LoRusso
Research Funding - Kyowa Hakko Kirin
E. A. Sausville
No relevant relationships to disclose
N. Rao
Employment or Leadership Position - Kyowa Hakko Kirin
E. Kobayashi
Employment or Leadership Position - Kyowa Hakko Kirin
M. R. Kurman
Consultant or Advisory Role - Kyowa Hakko Kirin
S. Akinaga
Employment or Leadership Position - Kyowa Hakko Kirin
G. K. Schwartz
No relevant relationships to disclose